VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway

Abstract Background Hyperglycemia and insulin resistance are among the key phenotypes of obesity and type 2 diabetes (T2DM). Notably, skeletal muscle fiber-type composition is closely linked to insulin resistance. Vascular endothelial growth factor B (VEGF-B) has been shown to play an important role...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu-liu Shi, Yu-ting Sun, Jia-nan Sun, Jing Yue, Wei Chen, Kun Meng, Long Chen, Chang-qing Hu, Rui Chen, Dong-sheng Sun, Cheng-bao Xu, Wei Yuan, Xin-li Li, Dan Zhao, Yan Wu, Shi-bing Xi, Xiao-ying Zhao, Jun-ming Tang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-025-04455-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238722878373888
author Liu-liu Shi
Yu-ting Sun
Jia-nan Sun
Jing Yue
Wei Chen
Kun Meng
Long Chen
Chang-qing Hu
Rui Chen
Dong-sheng Sun
Cheng-bao Xu
Wei Yuan
Xin-li Li
Dan Zhao
Yan Wu
Shi-bing Xi
Xiao-ying Zhao
Jun-ming Tang
author_facet Liu-liu Shi
Yu-ting Sun
Jia-nan Sun
Jing Yue
Wei Chen
Kun Meng
Long Chen
Chang-qing Hu
Rui Chen
Dong-sheng Sun
Cheng-bao Xu
Wei Yuan
Xin-li Li
Dan Zhao
Yan Wu
Shi-bing Xi
Xiao-ying Zhao
Jun-ming Tang
author_sort Liu-liu Shi
collection DOAJ
description Abstract Background Hyperglycemia and insulin resistance are among the key phenotypes of obesity and type 2 diabetes (T2DM). Notably, skeletal muscle fiber-type composition is closely linked to insulin resistance. Vascular endothelial growth factor B (VEGF-B) has been shown to play an important role in T2DM. However, the effects of VEGF-B on myofiber types in individuals with obesity or T2DM remain unclear. This study aimed to investigate the effects and mechanisms of VEGF-B on myofiber-type formation and regeneration. Methods Male Vegfb (vascular endothelial growth factor B) gene knockout mice and wild-type C57BL/6 male mice were fed either a normal diet or a high-fat diet. Double immunofluorescence staining and RNA-seq of skeletal muscle tissue from these mice were used to evaluate the role of VEGF-B in myofiber type regulation. To investigate the effects of VEGF-B on myoblast differentiation, fusion, and type I slow-twitch fiber formation in vitro, we prepared a novel in vitro model by continuous single-dose administration of VEGF-B, which was matched with physiological conditions and high-fat diet-induced hyperglycemia in vivo. Results VEGF-B deficiency attenuated high-fat diet-induced loss of slow-twitch type I myofibers and improved hyperglycemia and insulin resistance in mice. Continuous low-concentration administration of VEGF-B isoforms (VEGF-B186 and VEGF-B167) enhanced myoblast differentiation, fusion and myotube formation in a dose-dependent manner, whereas higher concentrations inhibited these processes, with VEGF-B186 exhibiting more pronounced effects. Notably, elevated VEGF-B levels, particularly VEGF-B186, suppressed mainly slow-twitch type I myofiber formation. Mechanistic studies revealed that high-dose VEGF-B186 (100 ng/mL) reduced myoblast differentiation/fusion and slow-twitch fiber formation via PKA-NFAT-MyoG/MEF2C signaling. Furthermore, high-dose VEGF-B186 decreased the expression of glucose transporter type 4, glucose utilization, and mitochondrial function in a unique myoblast cell model, effects that were reversed by PKA activators and NFATc1/c2 overexpression. Conclusion These findings demonstrate that VEGF-B is a key regulator of myofiber type composition and metabolic homeostasis in the context of obesity or T2DM. The inhibitory effects of elevated VEGF-B186 on slow-twitch fiber formation and glucose metabolism underscore its pathological role in obesity-related metabolic dysregulation. These results support the therapeutic potential of targeting VEGF-B186—via inhibitors or monoclonal antibodies— for obesity and T2DM, which are characterized by slow-twitch fiber depletion.
format Article
id doaj-art-c4fac1bbdc4e4e0e9ca8e2444c490679
institution Kabale University
issn 1757-6512
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-c4fac1bbdc4e4e0e9ca8e2444c4906792025-08-20T04:01:25ZengBMCStem Cell Research & Therapy1757-65122025-07-0116112110.1186/s13287-025-04455-7VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathwayLiu-liu Shi0Yu-ting Sun1Jia-nan Sun2Jing Yue3Wei Chen4Kun Meng5Long Chen6Chang-qing Hu7Rui Chen8Dong-sheng Sun9Cheng-bao Xu10Wei Yuan11Xin-li Li12Dan Zhao13Yan Wu14Shi-bing Xi15Xiao-ying Zhao16Jun-ming Tang17Hubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicinePediatrics Research Institute, Affiliated Taihe Hospital, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineHubei Key Laboratory of Embryonic Stem Cell Research, Department of Physiology, School of Basic Medicine, Hubei University of MedicineAbstract Background Hyperglycemia and insulin resistance are among the key phenotypes of obesity and type 2 diabetes (T2DM). Notably, skeletal muscle fiber-type composition is closely linked to insulin resistance. Vascular endothelial growth factor B (VEGF-B) has been shown to play an important role in T2DM. However, the effects of VEGF-B on myofiber types in individuals with obesity or T2DM remain unclear. This study aimed to investigate the effects and mechanisms of VEGF-B on myofiber-type formation and regeneration. Methods Male Vegfb (vascular endothelial growth factor B) gene knockout mice and wild-type C57BL/6 male mice were fed either a normal diet or a high-fat diet. Double immunofluorescence staining and RNA-seq of skeletal muscle tissue from these mice were used to evaluate the role of VEGF-B in myofiber type regulation. To investigate the effects of VEGF-B on myoblast differentiation, fusion, and type I slow-twitch fiber formation in vitro, we prepared a novel in vitro model by continuous single-dose administration of VEGF-B, which was matched with physiological conditions and high-fat diet-induced hyperglycemia in vivo. Results VEGF-B deficiency attenuated high-fat diet-induced loss of slow-twitch type I myofibers and improved hyperglycemia and insulin resistance in mice. Continuous low-concentration administration of VEGF-B isoforms (VEGF-B186 and VEGF-B167) enhanced myoblast differentiation, fusion and myotube formation in a dose-dependent manner, whereas higher concentrations inhibited these processes, with VEGF-B186 exhibiting more pronounced effects. Notably, elevated VEGF-B levels, particularly VEGF-B186, suppressed mainly slow-twitch type I myofiber formation. Mechanistic studies revealed that high-dose VEGF-B186 (100 ng/mL) reduced myoblast differentiation/fusion and slow-twitch fiber formation via PKA-NFAT-MyoG/MEF2C signaling. Furthermore, high-dose VEGF-B186 decreased the expression of glucose transporter type 4, glucose utilization, and mitochondrial function in a unique myoblast cell model, effects that were reversed by PKA activators and NFATc1/c2 overexpression. Conclusion These findings demonstrate that VEGF-B is a key regulator of myofiber type composition and metabolic homeostasis in the context of obesity or T2DM. The inhibitory effects of elevated VEGF-B186 on slow-twitch fiber formation and glucose metabolism underscore its pathological role in obesity-related metabolic dysregulation. These results support the therapeutic potential of targeting VEGF-B186—via inhibitors or monoclonal antibodies— for obesity and T2DM, which are characterized by slow-twitch fiber depletion.https://doi.org/10.1186/s13287-025-04455-7VEGF-BMyoblast differentiation/fusionMyofiber typesHyperglycemiaObesityT2DM
spellingShingle Liu-liu Shi
Yu-ting Sun
Jia-nan Sun
Jing Yue
Wei Chen
Kun Meng
Long Chen
Chang-qing Hu
Rui Chen
Dong-sheng Sun
Cheng-bao Xu
Wei Yuan
Xin-li Li
Dan Zhao
Yan Wu
Shi-bing Xi
Xiao-ying Zhao
Jun-ming Tang
VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway
Stem Cell Research & Therapy
VEGF-B
Myoblast differentiation/fusion
Myofiber types
Hyperglycemia
Obesity
T2DM
title VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway
title_full VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway
title_fullStr VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway
title_full_unstemmed VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway
title_short VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway
title_sort vegf b mediated myofiber types involved in high fat diet induced hyperglycemia through pka nfats signaling pathway
topic VEGF-B
Myoblast differentiation/fusion
Myofiber types
Hyperglycemia
Obesity
T2DM
url https://doi.org/10.1186/s13287-025-04455-7
work_keys_str_mv AT liuliushi vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT yutingsun vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT jianansun vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT jingyue vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT weichen vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT kunmeng vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT longchen vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT changqinghu vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT ruichen vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT dongshengsun vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT chengbaoxu vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT weiyuan vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT xinlili vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT danzhao vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT yanwu vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT shibingxi vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT xiaoyingzhao vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway
AT junmingtang vegfbmediatedmyofibertypesinvolvedinhighfatdietinducedhyperglycemiathroughpkanfatssignalingpathway